These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies. Bodey B; Siegel SE; Kaiser HE Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112 [TBL] [Abstract][Full Text] [Related]
29. Translation and Clinical Development of Bispecific T-cell Engaging Antibodies for Cancer Treatment. Yuraszeck T; Kasichayanula S; Benjamin JE Clin Pharmacol Ther; 2017 May; 101(5):634-645. PubMed ID: 28182247 [TBL] [Abstract][Full Text] [Related]
30. A New Generation of "Magic Bullets" for Molecular Targeting of Cancer. Capala J; Kunos CA Clin Cancer Res; 2021 Jan; 27(2):377-379. PubMed ID: 33144340 [TBL] [Abstract][Full Text] [Related]
31. Monoclonal antibody therapy of cancer. Jurcic JG; Scheinberg DA; Houghton AN Cancer Chemother Biol Response Modif; 1997; 17():195-216. PubMed ID: 9551215 [No Abstract] [Full Text] [Related]
32. Biotechnology-2009 AAPS national conference. 21-24 June 2009, Seattle, WA, USA. Wu C IDrugs; 2009 Sep; 12(9):539-42. PubMed ID: 19697269 [No Abstract] [Full Text] [Related]
34. Development of tetravalent IgG1 dual targeting IGF-1R-EGFR antibodies with potent tumor inhibition. Croasdale R; Wartha K; Schanzer JM; Kuenkele KP; Ries C; Mayer K; Gassner C; Wagner M; Dimoudis N; Herter S; Jaeger C; Ferrara C; Hoffmann E; Kling L; Lau W; Staack RF; Heinrich J; Scheuer W; Stracke J; Gerdes C; Brinkmann U; Umana P; Klein C Arch Biochem Biophys; 2012 Oct; 526(2):206-18. PubMed ID: 22464987 [TBL] [Abstract][Full Text] [Related]
35. The new face of bispecific antibodies: targeting cancer and much more. Lum LG; Davol PA; Lee RJ Exp Hematol; 2006 Jan; 34(1):1-6. PubMed ID: 16413384 [TBL] [Abstract][Full Text] [Related]
36. Bispecific antibodies: design, therapy, perspectives. Sedykh SE; Prinz VV; Buneva VN; Nevinsky GA Drug Des Devel Ther; 2018; 12():195-208. PubMed ID: 29403265 [TBL] [Abstract][Full Text] [Related]